BTAI

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioXcel Therapeutics Inc

NASDAQ | BTAI

2.25

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 23, 2025)

$44.40M

Market Cap

-

P/E Ratio

-11.9

EPS

$13.28

52 Week High

$1.17

52 Week Low

HEALTHCARE

Sector

BTAI Chart

Recent Chart
Price Action

BTAI Technicals

Tags:

BTAI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $123K
Total Revenue $2.3M
Cost Of Revenue $2.1M
Costof Goods And Services Sold $2.1M
Operating Income -$67M
Selling General And Administrative $33M
Research And Development $30M
Operating Expenses $67M
Investment Income Net -
Net Interest Income -$13M
Interest Income $2.6M
Interest Expense $15M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $309K
Income Before Tax -$60M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$44M
Net Income -$60M

Revenue & Profitability

Earnings Performance

BTAI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $38M
Total Current Assets $37M
Cash And Cash Equivalents At Carrying Value $30M
Cash And Short Term Investments $30M
Inventory $679K
Current Net Receivables $131K
Total Non Current Assets $944K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $6.7M
Other Non Current Assets -
Total Liabilities $131M
Total Current Liabilities $22M
Current Accounts Payable $16M
Deferred Revenue -
Current Debt -
Short Term Debt $748K
Total Non Current Liabilities $109M
Capital Lease Obligations $439K
Long Term Debt $103M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $103M
Other Current Liabilities $5.4M
Other Non Current Liabilities -
Total Shareholder Equity -$93M
Treasury Stock -
Retained Earnings -$650M
Common Stock $49K
Common Stock Shares Outstanding $2.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$72M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $309K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $1.3M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $37M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$60M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $123K
Total Revenue $2.3M
Cost Of Revenue $2.1M
Costof Goods And Services Sold $2.1M
Operating Income -$67M
Selling General And Administrative $33M
Research And Development $30M
Operating Expenses $67M
Investment Income Net -
Net Interest Income -$13M
Interest Income $2.6M
Interest Expense $15M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $309K
Income Before Tax -$60M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$44M
Net Income -$60M

BTAI News

BTAI Profile

BioXcel Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioXcel Therapeutics Inc. is an innovative clinical-phase biopharmaceutical company based in New Haven, Connecticut, specializing in harnessing artificial intelligence to revolutionize drug discovery and development, particularly in the fields of neuroscience and immuno-oncology. The company boasts a promising pipeline of therapies designed to address significant unmet medical needs, emphasizing its commitment to transforming patient care through novel therapeutics. By integrating state-of-the-art AI technologies with extensive scientific expertise, BioXcel is strategically positioned to lead advancements in an evolving healthcare landscape, making it an attractive consideration for institutional investors.

YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
UUUU
-6.50%
$21.26
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.65%
$7.79
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
NAKA
+10.41%
$0.79
YYAI
-50.60%
$0.09
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
YDKG
+5.58%
$0.07
F
-0.72%
$12.34
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
RGTI
+9.80%
$39.59
AIRE
+38.18%
$0.98
RIG
+13.74%
$3.89
TSLA
+2.28%
$448.98
INTC
+3.35%
$38.15
BURU
-5.27%
$0.34
VTYX
+70.98%
$6.60
NOK
+11.17%
$6.17
QBTS
+13.81%
$31.06
NVDA
+1.04%
$182.16
T
-3.63%
$24.62
ADAP
-3.44%
$0.07
MSAI
+101.73%
$1.35
AAL
+5.62%
$12.77
BITF
+5.71%
$4.16
VIVK
+5.68%
$0.26
WTO
-7.04%
$0.06
IONZ
-14.59%
$3.98
AREB
+75.34%
$3.77
AXDX
-61.36%
$0.03
DNN
+0.36%
$2.73
IONQ
+7.06%
$59.37
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
SMCI
-8.72%
$47.92
QUBT
+7.19%
$15.94
TLRY
+2.06%
$1.48
VZ
-3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB
+1.77%
$5.72
SOFI
+3.27%
$28.08
RBNE
+7.87%
$1.37
BBD
+1.51%
$3.35
JOBY
+1.29%
$15.67
RF
-0.04%
$24.10
CAN
+3.22%
$1.76
ETHD
-3.17%
$3.97
ACHR
+0.46%
$10.91
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
SGBX
+29.82%
$2.96
AMD
+2.06%
$234.99
BTG
+0.38%
$5.23
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
ONDS
+4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR
+2.84%
$180.48
LAES
+5.92%
$5.72
RXRX
-0.34%
$5.73
SRM
+53.27%
$10.30
CIFR
+7.10%
$17.25
PFE
-0.20%
$24.67
TNGX
-13.04%
$7.53
BTBT
+3.62%
$3.72
AAPL
+0.43%
$259.58
MARA
+0.36%
$19.22
AMC
-0.72%
$2.73
DVLT
+5.14%
$2.25
UUUU
-6.50%
$21.26
WBD
+3.50%
$21.25
AMZN
+1.44%
$221.09
IREN
+7.77%
$55.86
HPE
+0.43%
$23.19
PBR
+0.93%
$11.84
NIO
+0.73%
$6.89
IBIO
-8.63%
$1.27
CUTR
-10.19%
$0.09
KMI
-4.75%
$26.25
NVTS
+0.03%
$13.61
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
LUV
-6.25%
$31.65
RR
+7.11%
$5.42
TE
-9.73%
$3.71
ETWO
0.00%
$3.30
SCWO
+32.07%
$0.48
SNAP
+1.28%
$7.87
BAC
+1.29%
$51.76
RIVN
+1.31%
$13.09
BTE
+5.72%
$2.40
APLD
+9.01%
$33.38
DNUT
+1.98%
$4.11
HOOD
+5.58%
$134.33
LUMN
+10.65%
$7.79
VALE
-0.52%
$11.46
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
ERIC
-0.31%
$9.48
CLSK
+4.80%
$17.67
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
NAKA
+10.41%
$0.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.